3rd June 2024 (12 Topics)

Copy

1 Jun

3 Jun

4 Jun

5 Jun

6 Jun

7 Jun

8 Jun

10 Jun

11 Jun

12 Jun

13 Jun

14 Jun

15 Jun

17 Jun

18 Jun

19 Jun

20 Jun

21 Jun

22 Jun

24 Jun

25 Jun

26 Jun

27 Jun

28 Jun

29 Jun

Breakthrough in Nipah Virus Research

Context

Scientists at the Institute of Advanced Virology (IAV) developed a safe and effective way to generate non-infectious Nipah virus-like particles (VLPs) in the laboratory.

Key-highlights of the research:

This breakthrough provides a safer platform for research and development of treatments against the deadly Nipah virus (NiV) in a BSL-2 laboratory.
It brings researchers closer to developing monoclonal antibodies and antivirals against NiV and similar pathogens.
Characteristics of VLPs:
- VLPs closely resemble viruses but are non-infectious as they contain no viral genetic material.
- They carry most of the virus's characteristics, making them valuable tools for studying viral binding, entry kinetics, and immune responses.
HiBiT-Tagged NiV-VLPs:
Scientists created "HiBiT-tagged" Nipah virus-like particles (NiV-VLPs) using plasmid-based expression systems.
These VLPs are identical to the native virus but cannot replicate.
The inclusion of a highly sensitive HiBiT tag accelerates their potential in antiviral drug screening and vaccine development.
HiBiT-tagged VLPs offer reduced risks compared to using native viruses in research assays.
This method is applicable to other virulent pathogens and is advantageous for studying BSL-3/BSL-4 level viruses in lower bio-containment levels.

Fact Box: About Nipah Virus

Transmission: Nipah virus is a zoonotic virus, meaning it can spread from animals to humans. It can also be transmitted through contaminated food or directly between people.
Pathogenicity: This virus is highly dangerous, with a fatality rate of up to 80% in humans.
Hosts: Fruit bats (family Pteropodidae), especially those from the Pteropus genus, are the natural hosts for Nipah virus. Interestingly, fruit bats don't seem to get sick from it.
Treatment: Currently, there are no specific drugs or vaccines for Nipah virus infection. However, the World Health Organization (WHO) has recognized Nipah as a priority disease for research and development.
Research on Nipah virus has been limited because of the strict biosafety precautions required for handling this dangerous pathogen, which is classified as a BSL-4 pathogen.

The message from the Andhra Pradesh bifurcation

Polity & Governance Union and the States

China’s Proposal for a No-First-Use Treaty

International Relations International Organization

Indian Economy: We Still Have a Long Way Ahead

Economy Growth and Development

Addressing Poor Electricity Supply for Farmers

Polity & Governance Governance

Amendments to IHR 2005

Polity & Governance Governance

Inequality and Growth

Economy Growth and Development

Red Flag Exercise and RIMPAC Exercise

International Relations Military exercises

OPEC+ extends oil output cuts

Economy Trade and Commerce

China's Chang'e-6 Mission

Science & Technology Satellites and Launch Vehicles

Discovery of Earliest-known Galaxy by JWST

Science & Technology Space

GS Analyst: Daily Current Affairs

3rd June 2024 (12 Topics)

Copy

Breakthrough in Nipah Virus Research

Key-highlights of the research:

Fact Box: About Nipah Virus

Still Have Questions?

GS Analyst: Daily Current Affairs

Breakthrough in Nipah Virus Research

Key-highlights of the research:

Fact Box: About Nipah Virus

Still Have Questions?

User Login

User Register

Forgot Password

Verify Your Mobile Number